Young M A, Ehrenpreis E D, Ehrenpreis M, Kirshblum S
Albert Einstein College of Medicine/Montefiore Medical Center, Department of PM&R, Bronx, NY 10461.
Arch Phys Med Rehabil. 1989 Jun;70(6):468-70. doi: 10.1016/0003-9993(89)90009-9.
Heparin-associated thrombocytopenia and thrombosis (HATT) syndrome is a severe complication of heparin therapy. Since patients admitted for rehabilitation are at high risk for deep-vein thrombosis and pulmonary embolism, prophylactic doses of subcutaneous heparin are frequently used. We report the case of a 73-year-old woman with a history of heparin exposure, admitted to a comprehensive rehabilitation program for management of severe back pain. The patient was started on subcutaneous heparin. After 18 days of hospitalization, she developed marked thrombocytopenia and a massive venous thrombosis in the right lower extremity. On intravenous heparin therapy, the platelet count continued to decline. The thrombocytopenia resolved with discontinuation of heparin. This case illustrates a devastating complication of heparin therapy and emphasizes that physiatrists should be aware of this acute and preventable drug reaction.
肝素相关性血小板减少症和血栓形成(HATT)综合征是肝素治疗的一种严重并发症。由于因康复入院的患者发生深静脉血栓形成和肺栓塞的风险很高,因此经常使用皮下肝素的预防剂量。我们报告了一名73岁有肝素暴露史的女性病例,她因严重背痛入住综合康复项目。患者开始接受皮下肝素治疗。住院18天后,她出现了明显的血小板减少症以及右下肢的大量静脉血栓形成。在接受静脉肝素治疗后,血小板计数持续下降。停用肝素后血小板减少症得到缓解。该病例说明了肝素治疗的一种毁灭性并发症,并强调物理治疗师应意识到这种急性且可预防的药物反应。